Qvanteq develops the Qstent technology for self-expanding Nitinol based peripheral stents. These stents are used to treat blocked peripheral arteries or veins.
The Qstent technology was successfully integrated into fully functional device prototypes. Proof of concept, namely antithrombotic properties, fast endothelialization and handling, was demonstrated in flow loop studies using whole human blood and with human aortic endothelial cells.
For further information, please contact the company.